| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alliance for Aging Research AD Biomarkers Work Group: structural MRI
|
Jack Jr., Clifford R.
|
|
2011
|
32 |
S1 |
p. S48-S57
10 p.
|
artikel
|
| 2 |
Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia
|
Klunk, William E.
|
|
2011
|
32 |
S1 |
p. S20-S36
17 p.
|
artikel
|
| 3 |
Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants
|
Mayeux, Richard
|
|
2011
|
32 |
S1 |
p. S10-S19
10 p.
|
artikel
|
| 4 |
Changes in cognition
|
Albert, Marilyn S.
|
|
2011
|
32 |
S1 |
p. S58-S63
6 p.
|
artikel
|
| 5 |
Clinical trial methodologies for disease-modifying therapeutic approaches
|
Aisen, Paul S.
|
|
2011
|
32 |
S1 |
p. S64-S66
3 p.
|
artikel
|
| 6 |
Contents
|
|
|
2011
|
32 |
S1 |
p. v-
1 p.
|
artikel
|
| 7 |
CSF biomarkers for Alzheimer's disease: current utility and potential future use
|
Holtzman, David M.
|
|
2011
|
32 |
S1 |
p. S4-S9
6 p.
|
artikel
|
| 8 |
Editorial Advisory Board
|
|
|
2011
|
32 |
S1 |
p. IFC-
1 p.
|
artikel
|
| 9 |
Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments
|
Reiman, Eric M.
|
|
2011
|
32 |
S1 |
p. S44-S47
4 p.
|
artikel
|
| 10 |
Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview
|
Morris, John C.
|
|
2011
|
32 |
S1 |
p. S1-S3
3 p.
|
artikel
|
| 11 |
The potential of functional MRI as a biomarker in early Alzheimer's disease
|
Sperling, Reisa
|
|
2011
|
32 |
S1 |
p. S37-S43
7 p.
|
artikel
|
Tijdschrift beschrijving